Concepedia
Statistics
Publications
16
Citations
824
H-Index
13
Active since
2009
Affiliations
Sahlgrenska University Hospital(Current)
Oslo University Hospital
Helsinki University Hospital
Amsterdam University Medical Centers
University of Amsterdam
Svein Olav Bratlie is an author at Sahlgrenska University Hospital specializing in medicine, oncology, and pancreatic cancer.
Publications per year
2009–2025
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial
Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson et al. · The Lancet. Gastroenterology & hepatology · 2024 · 206 citations
Medicine, Oncology, Surgery +9
Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial
Maarten Korrel, L. Jones, Jony van Hilst et al. · The Lancet Regional Health - Europe · 2023 · 123 citations · Full text
Medicine, Oncology, Surgery +17
Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation
Jakob Kirkegård, Eirik Kjus Aahlin, Mohammed Al‐Saiddi et al. · British journal of surgery · 2019 · 68 citations · Full text
Medicine, Oncology, Radiology +17
Is transcatheter arterial embolization a safer alternative than surgery when endoscopic therapy fails in bleeding duodenal ulcer?
Linas Venclauskas, Svein Olav Bratlie, Karin Zachrisson et al. · Scandinavian Journal of Gastroenterology · 2009 · 56 citations
Medicine, Emergency Medicine, Surgery +15
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial
Jacob L. van Dam, Eva M. M. Verkolf, E.N. Dekker et al. · BMC Cancer · 2023 · 56 citations · Full text
Medicine, Oncology, Surgery +12
1–5 of 16